Residual mesorectal lymph node involvement following neoadjuvant combined-modality therapy: rationale for radical resection?
- 1 February 2004
- journal article
- Published by Springer Science and Business Media LLC in Annals of Surgical Oncology
- Vol. 11 (2), 187-191
- https://doi.org/10.1245/aso.2004.06.010
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- A Pathologic Complete Response to Preoperative Chemoradiation Is Associated With Lower Local Recurrence and Improved Survival in Rectal Cancer Patients Treated by Mesorectal ExcisionDiseases of the Colon & Rectum, 2003
- Long-Term Results of Local Excision for Rectal CancerAnnals of Surgery, 2002
- Transanal excision of locally advanced rectal cancers downstaged using neoadjuvant chemoradiotherapyJournal of the American College of Surgeons, 2002
- Assessing the predictive value of clinical complete response to neoadjuvant therapy for rectal cancer: an analysis of 488 patientsJournal of the American College of Surgeons, 2002
- Complete Response to Neoadjuvant Chemoradiation for Rectal Cancer Does Not Influence SurvivalAnnals of Surgical Oncology, 2001
- All patients with small intramural rectal cancers are at risk for lymph node metastasisDiseases of the Colon & Rectum, 1999
- Low rectal cancerDiseases of the Colon & Rectum, 1998
- Improved Survival with Preoperative Radiotherapy in Resectable Rectal CancerNew England Journal of Medicine, 1997
- Surgical cure for early rectal carcinomas (T1)Diseases of the Colon & Rectum, 1996
- Accuracy of endosonography in the staging of rectal cancer treated by radiotherapyBritish Journal of Surgery, 1991